PhD in Antibody-Drug Conjugate Engineering for Cancer
Gem dette job og hold din søgning organiseret
Opret en gratis konto for at gemme job, oprette underretninger og vende tilbage til denne fortegnelse fra dit dashboard.
Ved at fortsætte accepterer du vores Vilkår & Privatlivspolitik.
The Biotech Research and Innovation Centre (BRIC) at the University of Copenhagen invites applications for a 3-year PhD fellowship in antibody-drug conjugate (ADC) research. The successful candidate will join the group of Associate Professor Lars Henning Engelholm, with a start around 15 January 2027.
The project aims to engineer next-generation ADCs with improved internalization and lysosomal routing, including bispecific constructs, with in vivo testing and collaboration with Novo Nordisk
-
PhD fellowship in antibody-drug conjugate
3 dage siden
København, Region Hovedstaden, Danmark University of Copenhagen Fuldtid 323.000 kr. - 387.000 kr. KontraktBiotech Research and Innovation Centre (BRIC) / Finsen Laboratory, Faculty of Health and Medical Sciences, University of CopenhagenA 3-year PhD fellowship is available in the research group of Associate Professor Lars Henning Engelholm. Expected start: 15 January 2027, or as soon as possible thereafter.The projectAntibody-drug conjugates (ADCs) depend on...
-
Scientist, IHC and Target Expression
1 dag siden
København, Region Hovedstaden, Danmark PanTarg Fuldtid 650.000 kr. - 900.000 kr. KontraktPanTarg is a Danish biotechnology company developing novel anti-cancer therapies in the form of antibody-drug conjugates (ADCs) for the treatment of aggressive cancers with high unmet medical need. Our work is based on more than 30 years of research conducted at Rigshospitalet and University of Copenhagen, and our vision is to enable novel treatment options...
-
Associate Director, Tech Transfer Lead
3 dage siden
København, Region Hovedstaden, Danmark Genmab Fuldtid 624.000 kr. - 936.000 kr. KontraktAt Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions...